Literature DB >> 2323820

Suppression of tumor necrosis factor alpha production by a human immunoglobulin preparation for intravenous use.

T Shimozato1, M Iwata, N Tamura.   

Abstract

We investigated the effect of a pH 4-treated human immunoglobulin preparation for intravenous use (pH4-G) on the production of tumor necrosis factor alpha (TNF-alpha) in vivo. The level of TNF-alpha in the sera of rabbits receiving pH4-G before lipopolysaccharide (LPS) injection was lower than that in rabbits receiving only LPS. Similarly, the in vitro production of TNF-alpha was suppressed by pH4-G. Rabbit peritoneal exudate cells stimulated with LPS in the presence of pH4-G produced less TNF-alpha than did those stimulated only with LPS. pH4-G, however, had no effect on various TNF-alpha activities, such as cytotoxicity against tumorigenic murine fibroblasts (L929 cells), induction of interleukin-1 production, or fever induction. These results indicate that pH4-G suppresses TNF-alpha production without affecting TNF-alpha activities. A suppressive effect on the expression of TNF-alpha mRNA was also observed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323820      PMCID: PMC258636          DOI: 10.1128/iai.58.5.1384-1390.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes.

Authors:  E Sariban; K Imamura; R Luebbers; D Kufe
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 2.  Biological activities residing in the Fc region of immunoglobulin.

Authors:  E L Morgan; W O Weigle
Journal:  Adv Immunol       Date:  1987       Impact factor: 3.543

Review 3.  The common mediator of shock, cachexia, and tumor necrosis.

Authors:  B Beutler; A Cerami
Journal:  Adv Immunol       Date:  1988       Impact factor: 3.543

4.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

5.  Extraction and thin-layer chromatography of arachidonic acid metabolites.

Authors:  J A Salmon; R J Flower
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

6.  Regulation of tumour necrosis factor production by mouse peritoneal macrophages: the role of cellular cyclic AMP.

Authors:  Y Katakami; Y Nakao; T Koizumi; N Katakami; R Ogawa; T Fujita
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

7.  Human T cell hybridomas producing lymphokines. I. Establishment and characterization of human T cell hybridomas producing lymphotoxin and migration inhibitory factor.

Authors:  Y Kobayashi; M Asada; M Higuchi; T Osawa
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

8.  Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression.

Authors:  S L Kunkel; M Spengler; M A May; R Spengler; J Larrick; D Remick
Journal:  J Biol Chem       Date:  1988-04-15       Impact factor: 5.157

9.  Demonstration of a circulating suppressor factor of thymocyte proliferation during endotoxin fever in humans.

Authors:  C A Dinarello; L J Rosenwasser; S M Wolff
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

10.  Antipyretic activity of a human immunoglobulin preparation for intravenous use in an experimental model of fever in rabbits.

Authors:  M Iwata; T Shimozato; H Tokiwa; E Tsubura
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

View more
  8 in total

1.  Human immunoglobulin preparation for intravenous use induces elevation of cellular cyclic adenosine 3':5'-monophosphate levels, resulting in suppression of tumour necrosis factor alpha and interleukin-1 production.

Authors:  T Shimozato; M Iwata; H Kawada; N Tamura
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

2.  Use of intravenous immunoglobulin in critically ill patients.

Authors:  Summer Donovan; Gonzalo M L Bearman
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

3.  Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1 beta by peripheral blood monocytes in the acute phase of Kawasaki disease.

Authors:  H Suzuki; S Uemura; S Tone; T Iizuka; M Koike; K Hirayama; J Maeda
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

4.  Influence of polyclonal immunoglobulins on the polymorphonuclear leukocyte response to lipopolysaccharide of Salmonella enteritidis as measured with luminol-enhanced chemiluminescence.

Authors:  D R Wagner; D Heinrich
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

5.  Sera of patients with high titers of immunoglobulin G against Toxoplasma gondii induce secretion of tumor necrosis factor alpha by human monocytes.

Authors:  H Pelloux; B F Chumpitazi; F Santoro; B Polack; J P Vuillez; P Ambroise-Thomas
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

6.  Natural human IgG inhibits the production of tumor necrosis factor-alpha and interleukin-1 alpha through the Fc portion.

Authors:  A Horiuchi; Y Abe; M Miyake; Y Osuka; S Kimura
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

7.  Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG.

Authors:  U G Andersson; L Björk; U Skansén-Saphir; J P Andersson
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

8.  Intravenous Immunoglobulin Therapy Restores the Quantity and Phenotype of Circulating Dendritic Cells and CD4+ T Cells in Children With Acute Kawasaki Disease.

Authors:  Nana Wang; Zhongyue Chen; Fan Zhang; Qianwen Zhang; Ling Sun; Haitao Lv; Bo Wang; Jie Shen; Xufang Zhou; Feiyan Chen; Binwei Zhang; Lijun Meng; Huiting Zhou; ZhenJiang Bai; Jie Huang
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.